LOGC
LogicBio Therapeutics, Inc. Common Stock
LOGC
LOGC
Delisted
LOGC was delisted on the 15th of November, 2022.
63 hedge funds and large institutions have $69.8M invested in LogicBio Therapeutics, Inc. Common Stock in 2021 Q2 according to their latest regulatory filings, with 21 funds opening new positions, 11 increasing their positions, 16 reducing their positions, and 19 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less call options, than puts
Call options by funds: $ | Put options by funds: $
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
46% less capital invested
Capital invested by funds: $128M → $69.8M (-$58.5M)
Holders
63
Holding in Top 10
–
Calls
$5K
Puts
$7K
Top Buyers
| 1 | +$811K | |
| 2 | +$428K | |
| 3 | +$419K | |
| 4 |
TEE
Tibra Equities Europe
London,
United Kingdom
|
+$340K |
| 5 |
E
Ergoteles
New York
|
+$297K |
Top Sellers
| 1 | -$5.01M | |
| 2 | -$3.39M | |
| 3 | -$926K | |
| 4 |
JPMorgan Chase & Co
New York
|
-$818K |
| 5 |
GCP
GSA Capital Partners
London,
United Kingdom
|
-$807K |